CTOs on the Move

First Impressions

www.yoursafechild.com

 
First Impressions is a Phoenixville, PA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

illinois collection service

illinois collection service is a Tinley Park, IL-based company in the Business Services sector.

Comnet Canada

Comnet Canada Inc. is a Markham, ON-based company in the Business Services sector.

Mosaic ES

Mosaic ES is a Greenwood Vlg, CO-based company in the Business Services sector.

Broadside Enterprises

Broadside Enterprises, Inc. operates in entertainment media, distribution technologies, and commercial real estate businesses. Its Entertainment division, via its fully own subsidiary MonteCristo International Entertainment, focuses on the international sales and distribution of media assets as well as the development, financing, acquisition of scripted television series and feature films. This subsidiary currently manages over 100 feature films and documentaries and participates in most film and television markets worldwide. The company was incorporated in 1996 and is based in West Hollywood, California.

Biocartis

Biocartis is a molecular diagnostics company based in Mechelen, Belgium, founded in 2007. The company focuses on enhancing molecular testing through its proprietary Idylla TM Platform, which aims to make personalized medicine accessible by providing fast and convenient testing solutions suitable for various laboratory settings. Biocartis specializes in oncology diagnostics, offering a range of tests for cancers such as melanoma, colorectal, lung, brain, blood, and breast cancer. The Idylla Platform is a fully automated system that utilizes real-time PCR technology, enabling rapid in-house testing with results available in 30 to 150 minutes. In addition to oncology, Biocartis develops tests for infectious diseases, including panels for SARS-CoV-2, flu, and RSV, as well as the SeptiCyte RAPID test for host response. The company collaborates with major pharmaceutical and biotechnology firms, including Amgen and Bristol-Myers Squibb, to advance its testing capabilities and expand its diagnostic applications. Biocartis is committed to developing four to five new diagnostic applications each year, further enhancing its impact in the molecular diagnostics field.